<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30093565</article-id>
<article-id pub-id-type="pmc">6596165</article-id>
<article-id pub-id-type="publisher-id">0902-18</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.0902-18.2018</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
<subj-group>
<subject>Cellular/Molecular</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A Novel Alternative Splicing Mechanism That Enhances Human 5-HT1A Receptor RNA Stability Is Altered in Major Depression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-0065-398X</contrib-id>
<name>
<surname>Le François</surname>
<given-names>Brice</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Lei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mahajan</surname>
<given-names>Gouri J.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-1861-1013</contrib-id>
<name>
<surname>Stockmeier</surname>
<given-names>Craig A.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-6688-4932</contrib-id>
<name>
<surname>Friedman</surname>
<given-names>Eitan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-1809-3554</contrib-id>
<name>
<surname>Albert</surname>
<given-names>Paul R.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Department of Molecular, Cellular &amp; Biomedical Sciences, CUNY School of Medicine, Ph.D. Programs in Biochemistry and Biology, City University of New York, New York, New York, 10031, </aff>
<aff id="aff2"><sup>2</sup>Department of Cellular and Molecular Medicine, UOttawa Brain and Mind Research Institute, Ottawa Hospital Research Institute (Neuroscience), Ottawa, Ontario K1H 8M5, Canada, and </aff>
<aff id="aff3"><sup>3</sup>Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi 39216</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Dr. Paul R. Albert,
<addr-line>OHRI (Neuroscience), University of Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada.</addr-line><email>palbert@uottawa.ca</email></corresp>
<fn fn-type="con">
<p>Author contributions: B.L.F., C.A.S., E.F., and P.R.A. designed research; B.L.F., L.Z., and G.J.M. performed research; B.L.F., L.Z., G.J.M., C.A.S., E.F., and P.R.A. analyzed data; B.L.F., E.F., and P.R.A. wrote the paper.</p>
</fn>
<fn fn-type="equal" id="FN1">
<p>*E.F. and P.R.A. contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>19</day>
<month>9</month>
<year>2018</year>
</pub-date>
<volume>38</volume>
<issue>38</issue>
<fpage>8200</fpage>
<lpage>8210</lpage>
<history>
<date date-type="received">
<day>9</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 the authors 0270-6474/18/388200-11$15.00/0</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="zns03818008200.pdf"></self-uri>
<abstract>
<p>The serotonin-1A (5-HT1A) receptor is a key regulator of serotonergic activity and is implicated in mood and emotion. However, its post-transcriptional regulation has never been studied in humans. In the present study, we show that the “intronless” human 5-HT1A gene (<italic>HTR1A</italic>) is alternatively spliced in its 3′-UTR, yielding two novel splice variants. These variants lack a ∼1.6 kb intron, which contains an microRNA-135 (miR135) target site. Unlike the human <italic>HTR1A</italic>, the mouse <italic>HTR1A</italic> lacks the splice donor/accepter sites. Thus, in the mouse <italic>HTR1A</italic>, splicing was not detected. The two spliced mRNAs are extremely stable, are resistant to miR135-induced downregulation, and have greater translational output than the unspliced variant. Moreover, alternative <italic>HTR1A</italic> RNA splicing is oppositely regulated by the splice factors PTBP1 and nSR100, which inhibit or enhance its splicing, respectively. In postmortem human brain tissue from both sexes, <italic>HTR1A</italic> mRNA splicing was prevalent and region-specific. Unspliced <italic>HTR1A</italic> was expressed more strongly in the hippocampus and midbrain versus the prefrontal cortex (PFC), and correlated with reduced levels of nSR100. Importantly, <italic>HTR1A</italic> RNA splicing and nSR100 levels were reduced in the PFC of individuals with major depression compared with controls. Our unexpected findings uncover a novel mechanism to regulate <italic>HTR1A</italic> gene expression through alternative splicing of microRNA sites. Altered levels of splice factors could contribute to changes in regional and depression-related gene expression through alternative splicing.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> Alternative splicing, which is prevalent in brain tissue, increases gene diversity. The serotonin-1A receptor gene (<italic>HTR1A</italic>) is a regulator of serotonin, which is implicated in mood and emotion. Here we show that human <italic>HTR1A</italic> RNA is alternately spliced. Splicing removes a microRNA site to generate ultrastable RNA and increase <italic>HTR1A</italic> expression. This splicing varies in different brain regions and is reduced in major depression. We also identify specific splice factors for <italic>HTR1A</italic> RNA, showing they are also reduced in depression. Thus, we describe a novel mechanism to regulate gene expression through splicing. Altered levels of splice factors could contribute to depression by changing gene expression.</p>
</abstract>
<kwd-group>
<kwd>5-HT1A receptor</kwd>
<kwd>alternative splicing</kwd>
<kwd>major depression</kwd>
<kwd>RNA splice factors</kwd>
<kwd>RNA stability</kwd>
<kwd>serotonin</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>